Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PBM Safe Harbor Compliance May Cause “Difficulty” With Manufacturers

Executive Summary

The HHS Inspector General's compliance guide for the pharmaceutical industry could cause friction between manufacturers and pharmacy benefit management companies over conformity with safe harbors
Advertisement

Related Content

Formularies Would Be Authorized But Restricted Under Senate Medicare Bill
Formularies Would Be Authorized But Restricted Under Senate Medicare Bill
PBM Practice Standards May Be Defined By Settlements, Not IG Guide
Drug Manufacturer Education Grants To Purchasers May Be Kickback, IG Says
Drug Manufacturer Education Grants To Purchasers May Be Kickback, IG Says
IG Compliance Guide Will Change PBM Rebate Policies, AdvancePCS Says
Advertisement
UsernamePublicRestriction

Register

PS041974

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel